US gene-editing firm eGenesis closes $125m in Series C round

US gene-editing firm eGenesis closes $125m in Series C round

Source: Kameron Kincade/Unsplash

04 March, 2021

eGenesis gene-editing Qihan Biotech Yang Luhan

Printed by Unregistered user on Mon, 22 Dec 2025 22:35:30 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

SoftBank to invest $900m in US gene sequencing firm Pacific Biosciences

Vietnam's genetic testing firm Gene Solutions ropes in KPMG to raise $20m

Read more from Greater China

Chinese AI firm MiniMax to launch $700m Hong Kong IPO in early Jan

How China Inc. is discovering its new world in Brazil